Invention Application
US20100003246A1 Novel heterocyclic compounds and uses therof 失效
新型杂环化合物并使用

Novel heterocyclic compounds and uses therof
Abstract:
New substituted heterocyclic compounds, compositions containing them, and methods of using them for the inhibition of Raf kinase activity are provided. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0